🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ashley R. Tipton

ORCID: 0000-0003-0438-3726

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance”.

Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Cancer Research(2023)10.1158/0008-5472.can-22-3558

N/A

0.533DataRank · unranked

34 citations

Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou +9 more

Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.19.572069

N/A

0.165DataRank · unranked

2 citations

Tina Primeau, Maureen Highkin, Stephanie L. Pratt, Ashley R. Tipton, Nagalaxmi Vemalapally +9 more

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102700

N/A

0DataRank · unranked

11 citations

Haibo Xie, Miyang Li, Ang Gao, M Ma, Yidan Wang +8 more

Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.09.515796

N/A

0DataRank · unranked

0 citations

Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou +9 more